TCPI's purchase of Pharma Patch adds transdermal drug expertise to diagnostic business.
This article was originally published in The Tan Sheet
Executive Summary
TECHNICAL CHEMICALS' PROPOSED ACQUISITION OF PHARMA PATCH would add expertise in transdermal drug delivery to Technical Chemicals and Products' professional and OTC diagnostics business. The companies recently announced the signing of a letter of intent under which TCPI would acquire all the business assets and operations of Pharma Patch for $17 mil. "The marriage of these two companies' technologies will create a significant impact on both diagnostic and pharmaceutical markets," TCPI Chairman and President Jack Aronowitz predicted.